New Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action

dc.contributor.authorOhui, Kateryna
dc.contributor.authorAfanasenko, Eleonora
dc.contributor.authorBacher, Felix
dc.contributor.authorTing, Rachel Lim Xue
dc.contributor.authorZafar, Ayesha
dc.contributor.authorBlanco-Cabra, Núria
dc.contributor.authorTorrents Serra, Eduard
dc.contributor.authorDömötör, Orsolya
dc.contributor.authorMay, Nóra V.
dc.contributor.authorDarvasiova, Denisa
dc.contributor.authorEnyedy, Éva A.
dc.contributor.authorPopović-Bijelić, Ana
dc.contributor.authorReynisson, Jóhannes
dc.contributor.authorRapta, Peter
dc.contributor.authorBabak, Maria V.
dc.contributor.authorPastorin, Giorgia
dc.contributor.authorArion, Vladimir B.
dc.date.accessioned2023-05-26T11:46:53Z
dc.date.available2023-05-26T11:46:53Z
dc.date.issued2019-01-24
dc.date.updated2023-05-26T11:46:54Z
dc.description.abstractSix morpholine-(iso)thiosemicarbazone hybrids HL1-HL6 and their Cu(II) complexes with good-to-moderate solubility and stability in water were synthesized and characterized. Cu(II) complexes [Cu(L1-6)Cl] (1-6) formed weak dimeric associates in the solid state, which did not remain intact in solution as evidenced by ESI-MS. The lead proligands and Cu(II) complexes displayed higher antiproliferative activity in cancer cells than triapine. In addition, complexes 2-5 were found to specifically inhibit the growth of Gram-positive bacteria Staphylococcus aureus with MIC50 values at 2-5 μg/mL. Insights into the processes controlling intracellular accumulation and mechanism of action were investigated for 2 and 5, including the role of ribonucleotide reductase (RNR) inhibition, endoplasmic reticulum stress induction, and regulation of other cancer signaling pathways. Their ability to moderately inhibit R2 RNR protein in the presence of dithiothreitol is likely related to Fe chelating properties of the proligands liberated upon reduction.
dc.format.extent19 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec696607
dc.identifier.issn0022-2623
dc.identifier.urihttps://hdl.handle.net/2445/198520
dc.language.isoeng
dc.publisherAmerican Chemical Society
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1021/acs.jmedchem.8b01031
dc.relation.ispartofJournal of Medicinal Chemistry, 2019, vol. 62, num. 2, p. 512-530
dc.relation.urihttps://doi.org/10.1021/acs.jmedchem.8b01031
dc.rightsCC BY (c) Ohui, Kateryna et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject.classificationCèl·lules
dc.subject.classificationInhibició
dc.subject.classificationCàncer
dc.subject.otherCells
dc.subject.otherInhibition
dc.subject.otherCancer
dc.titleNew Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
696607.pdf
Mida:
5.64 MB
Format:
Adobe Portable Document Format